dc.contributorUniversidade Federal de São Carlos (UFSCar)
dc.contributorUniversidade de São Paulo (USP)
dc.contributorMermaid Beach Sportsmedicine Clinic
dc.contributorGriffith University
dc.contributorGold Coast Campus
dc.date.accessioned2022-04-28T19:03:29Z
dc.date.accessioned2022-12-20T01:01:22Z
dc.date.available2022-04-28T19:03:29Z
dc.date.available2022-12-20T01:01:22Z
dc.date.created2022-04-28T19:03:29Z
dc.date.issued2014-01-01
dc.identifierProceedings of the WALT Biennial Congress and NAALT Annual Conference, p. 45-54.
dc.identifierhttp://hdl.handle.net/11449/220602
dc.identifier2-s2.0-84962898770
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5400731
dc.description.abstractThe aim of this study was to investigate if the infrared laser irradiation can prevent or minimize delayed onset muscle soreness (DOMS). Eight healthy male were divided in two groups: laser group and sham laser group. All volunteers were submitted to an Eccentric Exercise Protocol (EEP) for biceps brachii to induce muscle damage. Active laser (780 nm; 50 mW; 500 mW/cm2; 12 J/cm2; energy of 5 J per point applied for 20 s on four points) or sham were applied two times, before and after EEP. Maximal voluntary contraction, range of motion, muscle soreness, creatine kinase activity, lactate, C-reactive problem, IL-6, IL-8, Ferric Reducing Capacity of Plasma and total bilirubin were analyzed before, 8, 24, 48, 72, 120 and 168 h after EEP. LLLT decreased IL-6 levels after 8 h of eccentric exercise in laser group. No significant differences were observed in other systemic markers of inflammation, antioxidant status or in muscle performance between groups. The results suggest a partial attenuation of muscle damage, as laser therapy was able to reduce IL-6 levels.
dc.languageeng
dc.relationProceedings of the WALT Biennial Congress and NAALT Annual Conference
dc.sourceScopus
dc.subjectBiceps braquii muscle
dc.subjectEccentric muscle training
dc.subjectInflammatory biomarkers
dc.titleLow-level laser therapy (LLLT) as a possible resource to attenuate muscle damage in delayed onset muscle soreness (DOMS)
dc.typeActas de congresos


Este ítem pertenece a la siguiente institución